To hear about similar clinical trials, please enter your email below
Trial Title:
Experience in Borderline Ovarian Tumors
NCT ID:
NCT05791838
Condition:
Borderline Ovarian Tumor
Conditions: Official terms:
Ovarian Neoplasms
Conditions: Keywords:
Conservative surgery
Micropapillary patterns
Surgical staging
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Retrospective
Summary:
Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and
represent an independent disease entity among epithelial ovarian cancers. The present
study aimed to report the 8-year experience of a single center on the management and
outcomes of consecutive BOTs patients. From January 2010 to December 2017, all patients
with BOTs undergoing surgical treatment were included. Demographic, clinical, and
pathological data were reviewed retrospectively.
Criteria for eligibility:
Study pop:
Patients surgically treated for borderline ovarian tumors (BOT)
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Age > 18 years,
- Patients affected by borderline ovarian tumors (BOT) of any histological type and
any FIGO stage,
- Women undergoing surgical treatment with both laparoscopic and laparotomic
approaches.
Exclusion Criteria:
- Women affected by ovarian cancers
Gender:
Female
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Start date:
March 2023
Completion date:
March 2023
Lead sponsor:
Agency:
University of Palermo
Agency class:
Other
Source:
University of Palermo
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05791838
